Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Sell
509,121
-17,222
-3% -$459K 3.7% 8
2025
Q4
$13.1M Sell
526,343
-5,001
-0.9% -$126K 3.26% 8
2025
Q3
$13.5M Buy
531,344
+2,539
+0.5% +$62.7K 3.44% 7
2025
Q2
$12.8M Buy
528,805
+12,259
+2% +$286K 3.52% 8
2025
Q1
$13.1M Sell
516,546
-4,308
-0.8% -$113K 4.36% 5
2024
Q4
$13.8M Buy
520,854
+442,360
+564% +$12M 4.6% 5
2024
Q3
$2.27M Sell
78,494
-2,800
-3% -$81.7K 0.83% 29
2024
Q2
$2.27M Buy
81,294
+16,053
+25% +$442K 0.73% 30
2024
Q1
$1.81M Buy
65,241
+22,844
+54% +$634K 0.59% 37
2023
Q4
$1.22M Buy
42,397
+22,510
+113% +$680K 0.45% 45
2023
Q3
$660K Buy
19,887
+735
+4% +$26K 0.27% 62
2023
Q2
$702K Sell
19,152
-5,681
-23% -$221K 0.28% 59
2023
Q1
$1.01M Sell
24,833
-5,427
-18% -$234K 0.42% 48
2022
Q4
$1.55M Sell
30,260
-183
-0.6% -$8.77K 0.69% 33
2022
Q3
$1.33M Buy
30,443
+259
+0.9% +$12.6K 0.6% 37
2022
Q2
$1.58M Sell
30,184
-1,789
-6% -$91.2K 0.69% 35
2022
Q1
$1.66M Sell
31,973
-2,387
-7% -$124K 0.68% 34
2021
Q4
$2.03M Buy
34,360
+5,967
+21% +$296K 0.85% 28
2021
Q3
$1.22M Buy
28,393
+723
+3% +$32K 0.5% 42
2021
Q2
$1.08M Buy
27,670
+2,349
+9% +$91.3K 0.45% 42
2021
Q1
$917K Buy
+25,321
New +$899K 0.4% 42
2019
Q3
Sell
-5,892
Closed -$242K 61
2019
Q2
$242K Buy
5,892
+33
+0.6% +$1.31K 0.27% 53
2019
Q1
$2.36K Sell
5,859
-641
-10% -$25.7K 0.26% 53
2018
Q4
$269K Sell
6,500
-136
-2% -$5.65K 0.27% 45
2018
Q3
$277K Sell
6,636
-293
-4% -$11.3K 0.26% 46
2018
Q2
$239K Buy
6,929
+17
+0.2% +$581 0.23% 50
2018
Q1
$233K Buy
+6,912
New +$238K 0.25% 50

Other funds holding PFE

WP Advisors's PFE Position: Q1 2026 in Review

WP Advisors reduced its Pfizer (PFE) stake by 3.3% in Q1 2026, selling an estimated $459K and leaving 509,121 shares worth $14.3M. The position accounts for 3.7% of the portfolio, ranked #8.

WP Advisors first reported a position in PFE in Q1 2018 and has held it in 27 quarters since. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • WP Advisors held 509,121 shares of Pfizer worth $14.3M as of Q1 2026.
  • WP Advisors sold 17,222 Pfizer shares in Q1 2026, an estimated $459K.
  • Pfizer made up 3.7% of WP Advisors's portfolio in Q1 2026, its #8 holding.
  • WP Advisors first reported a position in Pfizer in Q1 2018 and has held it in 27 quarters since.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on WP Advisors's 13F filing for Q1 2026, filed 4 May 2026.